BLUEPRINT MEDICINES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105 USD | -1.58% |
|
-1.63% | +13.79% |
| 14/05 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
| 06/05 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Other Biotechnology & Medical Research | -1.58% | -1.63% | +13.79% | +92.73% | +29.10% | 667.75Cr |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BPMC Stock
- Charts Blueprint Medicines Corporation
- Comparison Chart
